KDI-792

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameKDI-792

Drug Alias NameFR-121070KDI-792FK-070

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionThromboxane A2 synthase inhibitorsThromboxane A2 receptor antagonists

TargetsThromboxane A2 synthaseThromboxane A2 receptor

Therapy Area/IndicationsPeripheral Vascular DiseasesCerebrovascular Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsPeripheral Vascular DiseasesCerebrovascular Disorders

ATC CodeN/A